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ABSTRACT
To test the role of CACCC box on g-globin gene
activation, the CACCC box was deleted or mutated
and g-gene expression was monitored in transgenic
mice. Disruption of the CACCC box had no effect
on g-gene expression in the cells of embryonic
erythropoiesis but it strikingly reduced g-gene exp-
ression in fetal erythropoiesis, and abolished g-gene
expression in adult erythroid cells. The CACCC
mutation diminished HS formation, as well as TBP
and polII recruitment at the g-gene promoter;
however, it only resulted in slight or no effects on
histone H3 and H4 acetylation in adult erythro-
poiesis. Our findings indicate that each basic
cis element of the proximal g-gene promoter, i.e.
CACCC, CCAAT or TATA box, can be disrupted
without affecting the activation of g gene in embry-
onic erythroid cells. We propose that the trans
factors recruited by the three boxes interact with
each other to form a ‘promoter complex’. In embry-
onic erythropoiesis the locus control region
enhancer is able to interact with the complex even
when components normally binding to one of the
motifs are missing, but it can only activate an
intact ‘promoter complex’ in adult erythroid cells.
INTRODUCTION
The CACCC box was initially recognized as a regulatory
element by sequence homology analysis and mutation assays
(1–7) and is found in a large number of genes, in a broad
spectrum of species, including plants (8). The CACCC box
usually resides 100–200 bp 50 to the TATA box. Disruption
of the CACCC box results in diminution of promoter activity
in in vitro transcription or in cell transfection assays, sug-
gesting that the CACCC box positively contributes to the
promoter strength. Recently, it was reported that several
CACCC-binding factors could function as repressors (9).
However, a mutation that increases gene expression by
disrupting the CACCC box has not been found either using
a reporter gene assay or in vivo.
To date, the in vivo function of the CACCC box has been
assessed only in the globin gene locus. A CACCC box is pre-
sent in all the promoters of the globin genes and in DNase I
hypersensitive sites (HS) 2, 3 and 4 of the b locus control
region (LCR) (10). The functional signiﬁcance of the
b gene CACCC box has been well established by various
assays, and by in vivo evidence that mutations of this regula-
tory element result in the phenotype of b thalassemia (11). A
b-globin gene activator, EKLF, has been identiﬁed to bind
speciﬁcally to the CACCC box of the b-globin gene (12).
In the mouse, homozygosity for EKLF gene deletions is
lethal by days 14–15 of fetal development due to the absence
of b-globin gene expression and effects on other genes of
the deﬁnitive erythropoiesis (13,14). Thus, these results
unequivocally validated the hypothesis that the CACCC
box functions as a positive promoter element in vivo.T h e
function of the g-globin gene CACCC-box has been studied
in the context of the competition model of hemoglobin
switching, which hypothesizes that the expression of the
g-globin gene precludes expression of the b gene in embry-
onic erythropoiesis by competing for the enhancing activity
of the LCR. Townes and co-workers (15) demonstrated that
an intact human g-globin gene CACCC box was essential
for correct human b-globin gene regulation in transgenic
mice. When this site is mutated in the context of a cosmid
construct containing the 22 kb LCR, the b-globin gene is
expressed at high levels in embryonic erythroid cells. In addi-
tion, this study showed that disruption of the g CACCC box
did not abolish g-gene expression in the embryos. Similar
results were obtained in the transgenic mice carrying a
HS2/HS3gbplasmid construct (16). In transgenic mice carry-
ing the plasmid construct, the g gene was highly expressed in
deﬁnitive erythroid cells. Disruption of the CACCC box
abolished g-gene expression in the fetal and adult stages of
development, whereas it reduced g-gene expression by
 3-fold in the 10.5 day yolk sac.
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potential of the g-globin gene promoter in vivo, we produced
deletions and mutations of the g-gene promoter and examined
their effects in transgenic mice. Our ﬁndings show that the
CACCC box is not required for g-gene activation in primitive
erythropoiesis but it is necessary for g-gene expression in the
cells of deﬁnitive erythropoiesis. The CACCC mutations
diminished DNase I hypersensitivity and the recruitment of
polII and TBP at the g-gene promoter in adult erythropoiesis;
however, they had only slight or no effect on the acetylation
status of histone H3 and H4. These results are similar to
our previous ﬁndings showing that the g-gene expression in
embryonic erythroid cells is not disrupted by the CCAAT
or TATA box mutations (17,18). Taking these ﬁndings
together, we hypothesize that the trans factors recruited by
the CACCC, CCAAT and TATA boxes interact with each
other to form a large complex, which in the following discus-
sion we designate as the ‘promoter complex’. It is likely that
in the embryonic stage of development, functions of a trans
factor which fails to be recruited into the complex because
of a mutated promoter box is compensated by those factors
recruited by the remaining cis elements. As a results, the
LCR interacts with this incomplete ‘promoter complex’ in
embryonic erythroid cells. In contrast, an intact ‘promoter
complex’ is required for the interaction with the LCR in
adult erythroid cells.
MATERIALS AND METHODS
Constructs
The plasmid constructs, mLCR–382
Ag(DCAC  138 to  156)
(construct A), mLCR–382
Ag( 142 CC!TG) (construct B)
and mLCR–382
Ag( 140 A!C) (construct C) were con-
structed by standard oligonucleotide-directed mutagenesis
(Promega) on the basis of the parental construct
mLCR–382
Ag. (19). The mutations were veriﬁed by DNA
sequencing. The construct DNA fragment was relieved
from the plasmid backbone by restriction enzyme digestion
and separated by electrophoresis on 0.8% agarose gel. The
fragment was recovered from the gel by freeze–thaw cycle
and ﬁltered from an Ultrafree MC tube (Millipore). The
DNA fragment was further puriﬁed by phenol and chloroform
extraction and precipitated with ethanol. The DNA was resus-
pended in the low TE buffer (10 mM Tris–HCl, pH 7.5 and
0.1 mM EDTA) and diluted to 1–3 ng/ml. The DNA solution
was ﬁltered again through a syringe ﬁlter (Corning) just
before microinjection.
Transgenic mice
Puriﬁed DNA fragments were injected into fertilized mouse
eggs (B6/C3F1) and then transferred to pseudopregnant foster
mother (B6/D2F1). Founder animals were identiﬁed by
slot blotting with a HS3 probe. F1 progeny were obtained
by breeding founder animals with non-transgenic mice
(B6/D2F1) and were screened for correct integration and
to exclude the presence of mosaicism in the founders. To
study the developmental pattern of human g-gene expression,
staged pregnancies were interrupted on day 12 of develop-
ment and samples from blood yolk sac and fetal liver were
collected.
DNA analysis
DNA from fetal brain or carcass of F2 progeny in each line
was isolated by standard procedures. At least three DNA
samples were obtained from each line. Individual samples
were then digested with a restriction enzyme. DNA (10 mg)
from each enzyme reaction performed on samples from a
given line was loaded onto a 0.8% agarose gel, and DNA
fragments were resolved by electrophoresis. Southern blot
hybridization was performed with a BamHI–EcoRI probe
derived from the large intron of the g-globin gene. Signals
were quantiﬁed on a PhosphorImager. The blot was then
striped and rehybridized with a mouse a-globin gene probe
and the intensity of the signals on each lane was used for
DNA loading correction. Copy numbers were determined
by comparing the signal from a given transgenic line with
those of human genomic DNA. In cases in which the com-
puted value was not an integer, the copy number was rounded
to the nearest integer in standard fashion.
RNA analysis
Total RNA was prepared from the tissues containing
the primitive erythrocytes (d12 blood and yolk sac) and the
tissues containing the deﬁnitive erythrocytes (d12 fetal liver
and adult blood). RNA samples were separately isolated
from three or more transgenic individuals from each time
point. The human g-globin and murine a- and z-globin
mRNA was detected by RNase protection assay and quanti-
ﬁed by a PhosphorImager. To minimize experimental
error, samples from individual animals were quantiﬁed
independently and multiple measurements were performed
in RNase protection. Copy number-corrected globin mRNA
levels were expressed as human g mRNA/g copy number/
(murine z mRNA/2 + murine a mRNA/4).
DNase I hypersensitive assay
Single-cell spleen suspensions were prepared from
phenylhydrazine-treated 10- to 12-week-old transgenic mice.
Nuclei isolation, DNase I digestion and Southern blotting
were performed as described previously (20). The probe
shown in Figure 1 was a BamHI/EcoRI fragment encompass-
ing intron 2 of the g gene. DNase I was purchased from
Worthington Biochemical Corporation (Lakewood, NJ).
Chromatin immunoprecipitation assay (ChIP)
Single-cell spleen suspensions were prepared from 10- to
12-week-old transgenic mice after 4 days of phenylhydrazine-
induced hemolytic anemia. ChIP assays were performed as
described previously with modiﬁcations (17). The mouse the
b
maj globin gene was selected as internal controls. Immunopre-
cipitations (IP) were performed at least three times on different
days. Each DNA was diluted at three dilutions and the PCR
readings of the three dilutions should be within the range of
the standard DNA curve. PCR was performed on an Opticon
2 (MJ Research). All data were expression as ratio of the
PCR readings of a given primer set over the internal control
and SD was shown. Rabbit polyclonal antibodies against
histone H3 acetylated at lysines 9 and 14 and H4 at lysines
5, 8, 12 and 16 were purchased from Upstate Biotechnology
(Lake Placid, NY). Rabbit polyclonal antibodies against
3910 Nucleic Acids Research, 2006, Vol. 34, No. 14Pol II (N-20, sc-899) were obtained from Santa Cruz
Biotechnology (Santa Cruz, CA). Syber green PCR kit was
from Qiagen (Valencia, CA).
Gel shift assay
MEL nuclear extracts were prepared as described by
Andrews and Faller (21). In detail,  3 · 10
7 logarithmic-
phase MEL cells were harvested and washed once with
ice-cold PBS. The cells were then incubated in 2 ml of
ice-cold Buffer A [10 mM HEPES–KOH, pH 7.9, 1.5 mM
MgCl2, 10 mM KCl, 0.5 mM DTT and 0.2 mM phenyl-
methylsulfonyl ﬂuoride (PMSF)] for 10 min on ice. The sus-
pension was centrifuged at 10 000 g for 10 s. The pellet was
resuspended in 500 ml ice-cold buffer C (20 mM HEPES–
KOH, pH 7.9, 25% glycerol, 1.5 mM MgCl2, 420 mM
NaCl, 0.2 mM EDTA, 0.5 mM DTT and 0.2 mM PMSF)
and incubated on ice for 30 min. The crude nuclear extract
was obtained after the cellular debris was removed by cen-
trifugation at 12000 g for 30 min at 4 C. Protein concentra-
tion was determined by using the Bio-Rad protein assay kit.
The labeled probes (1 · 10
4 c.p.m.) were incubated with 5 mg
MEL nuclear extracts for 20 min at room temperature, in the
binding buffer containing 10 mM Tris–HCl, pH 7.5, 50 mM
NaCl, 0.5 mM DTT, 10% glycerol, 1 mg poly(dI–dC), 0.05%
NP-40 and competitors of various-concentration. Samples
were electrophoresed in 4.5% polyacrylamide gel in 0.5·
Tris–borate–EDTA (TBE) buffer containing 4 mM Mg
2+ at
4 C. The oligonucleotide sequences used in the assays was
shown in Figure 4A.
RESULTS
The CACCC box is required for human g-globin gene
expression in the adult but not in the embryonic
erythropoiesis
Truncation of the g-gene promoter to position
 141 g abolishes g-gene expression in the adult red cells
of transgenic mice, presumably because this truncation
destroys the g-gene CACCC box (19). Extension of the
g-gene promoter to  159 g (which includes the g CACCC
box) results in a 28-fold increase in g mRNA production
compared to the  141
A g transgenic mice (g/a mRNA
increased from 0.5 ± 0.3 to 14.3 ± 3.3) (19). To further test
the role of the g CACCC box on g-gene expression, we
deleted an 18 bp sequence (from  138g to  156g) encom-
passing the CACCC box in the context of the  382g
promoter. Five transgenic lines (Table 1) carrying
the mLCR( 382)
Ag(DCAC) construct were established and
g-gene expression was measured during development. As
shown in Table 1 (construct A), deletion of the CACCC
box region results in reduction of g-gene expression in the
fetal and adult stages of deﬁnitive erythropoiesis. g mRNA
levels in blood of adult mLCR(–382)
Ag(DCAC) mice were
16-fold lower than in the mLCR( 382)
Ag control mice.
These results provide in vivo evidence that the CACCC box
region is required for g-gene expression in the deﬁnitive ery-
thropoiesis of fetal liver and it is necessary for g-gene expres-
sion in adult red cells.
The deletion of the 18 bp CACCC region removed more
base pairs than required for a binding site of a putative
Kru  ppel-like transcription factor, which recognizes a 9 bp
motif. This raised the possibility that the phenotype observed
in the CACCC deletion mice might be due to the removal of
other DNA-binding sites in the region that are essential
for g expression. To address this question we destroyed the
g CACCC binding activity by introducing point mutations
into the box (CACCC!CATGC). These mutations destroyed
the protein-binding activity of the CACCC box as determined
by gel shift assay (see below). The mutation did not impair
g-gene expression in embryonic erythropoiesis (blood and
yolk sac at d12) in the ﬁve transgenic lines mice carrying
this construct (Table 1, construct B). In contrast, the mutation
resulted in striking decrease of g-gene expression in adult
erythropoiesis. Thus, g mRNA in the adult blood of the
CACCC mutant mice was reduced to 1.1% of murine a
mRNA, i.e. to the same level as that in the mice carrying
the deletion of the CACCC region. These results conﬁrm
that the g CACCC box per se is essential for g-gene expres-
sion in adult erythropoiesis.
In contrast to its role in g-gene expression in deﬁnitive
cells, the CACCC box region is not required for g-gene
expression in embryonic cells. As shown in Table 1,
there is essentially no difference in g mRNA levels between
the wild-type control and the CACCC deleted or mutant
transgenic mice in embryonic blood and yolk sac
samples. These results show that the g gene can be efﬁciently
expressed in embryonic cells in the absence of a g CACCC
box. The non-essential role of the CACCC box in
g-gene expression at the embryonic stage of development
has been reported by Ryan et al. (15) and Sargent and
Lloyd (16).
Table 1. g-Gene expression in transgenic mice carrying the various CACCC
box mutant constructs
Line Copy
number
Human g % of murine a-like mRNA per copy
Primitive erythropoiesis Definitive erythropoiesis
d12 d12 d12 Adult
Blood Yolk sac Fetal liver Blood
Construct A: mLCR-382
Ag(DCAC)
A-1 4 14.4 ± 0.7 18.0 ± 3.9 8.7 ± 0.7 1.5 ± 0.3
A-2 7 10.0 ± 1.6 16.1 ± 3.1 5.1 ± 0.4 0.9 ± 0.2
A-3 35 5.0 ± 0.9 9.8 ± 2.1 2.1 ± 0.4 0.5 ± 0.1
A-4 5 13.1 ± 2.2 16.5 ± 2.1 6.7 ± 0.5 1.1 ± 0.2
A-5 7 11.4 ± 2.4 11.4 ± 2.5 3.3 ± 0.7 0.3 ± 0.1
Mean 10.8 ± 3.6 14.4 ± 3.6 5.2 ± 2.6 0.9 ± 0.5
Construct B: mLCR-382
Ag(mut CAC)
B-1 2 11.7 ± 0.3 14.7 ± 2.2 1.6 ± 0.1 0.0
B-2 16 17.2 ± 2.7 30.6 ± 7.0 4.7 ± 1.1 1.4 ± 0.2
B-3 1 9.2 ± 3.0 14.4 ± 2.3 1.3 ± 1.1 0.0
B-4 11 20.4 ± 1.1 29.9 ± 4.6 7.2 ± 0.9 1.8 ± 0.4
B-5 7 18.5 ± 2.3 26.8 ± 4.6 5.0 ± 1.0 2.5 ± 0.3
Mean 15.4 ± 4.7 23.3 ± 8.1 4.0 ± 2.5 1.1 ± 1.1
Construct C: mLCR-382
Ag( 140 A!C)
C-1 5 21.3 ± 2.6 29.2 ± 6.0 17.3 ± 7.0 14.7 ± 2.0
C-2 12 17.3 ± 1.8 34.5 ± 5.8 20.2 ± 0.7 14.4 ± 2.1
C-3 1 13.8 ± 2.1 22.8 ± 3.1 24.8 ± 3.2 16.1 ± 2.5
C-4 3 23.3 ± 3.4 29.4 ± 1.4 29.1 ± 3.3 14.8 ± 3.6
C-5 6 16.7 ± 3.7 26.7 ± 5.8 18.3 ± 2.5 13.9 ± 1.6
C-6 3 7.9 ± 2.8 12.4 ± 2.7 4.5 ± 1.4 2.8 ± 0.5
C-7 4 10.3 ± 1.0 12.7 ± 2.3 5.2 ± 0.7 2.2 ± 0.4
Mean 15.8 ± 5.6 24.0 ± 8.5 17.1 ± 9.3 11.3 ± 6.0
Control : mLCR-382
Ag*
Mean 10.4 ± 9.5 21.0 ± 7.4 11.8 ± 2.8 16.5 ± 4.5
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To delineate the mechanistic relationship between
the CACCC box and g gene activation, we compared the
chromatin conformation in transgenic mice carrying the wild
type and in mice carrying the  142 CC!TG CACCC box
mutant constructs. The DNase I hypersensitivity assay was
performed on spleens of phenylhydrazine-treated adult trans-
genic mice. This treatment induces acute anemia,resulting ina
great expansion of erythropoiesis in the spleen so that ery-
throblasts account for >80% of splenic cells. Figure 1 shows
Southern blot hybridization results of DNase I sensitivity
assay. In wild-type mice, HS sites were formed in the LCR
as well as in the g gene promoter (Figure 1A). The CACCC
mutation disrupted HS formation at the g-gene promoter, but
had no effect on the LCR region (Figure 1B). These results
suggest that the effect of the CACCC mutation on chromatin
structure is conﬁned to the g-gene region.
Effects of the g CACCC mutation on histone acetylation
were determined by ChIP assays using antibodies against
histone H3 (acetylated K9, 14) or H4 (acetylated K5, 8, 12,
16). Levels of histone acetylation were expressed as fold
over that at the b
maj gene promoter, i.e. an endogenous mur-
ine gene in which the histone acetylation level should be
same in the wild type and in the CACCC mutant transgenic
mice. As shown in Figure 2A the CACCC mutation did not
affect the acetylation levels of histone H3 in the LCR region,
whereas it slightly reduced acetylation levels in the g-gene
region. The differences in the promoter, exon 2, and 30 region
region between the wild type and the CACCC mutant are sta-
tistically signiﬁcant (P < 0.05, from eight independent ChIP
experiments). On the other hand, the CACCC mutation did
not have any effects on histone H4 acetylation either in the
LCR or in the g-gene region (Figure 2B).
Taken together, these results suggest that the effects of the
CACCC mutation on chromatin conformation are restrained
to the g-gene region.
Effects of the CACCC mutation on pol II and
TBP recruitment
The CACCC mutation severely impaired recruitment of pol II
and TBP at the g gene promoter. As shown in Figure 2C and
D, pol II binding at the g-gene promoter in the control mice
was equivalent to 21 ± 0.2% of that at the mouse b
maj gene
promoter, whereas the corresponding measurement in the
CACCC mutant mice was 3.4 ± 0.8% of that at the b
maj
gene promoter. Thus, the CACCC mutation resulted in an
86% reduction of pol II recruitment at the g-gene promoter.
Similarly, the CACCC mutation caused an 88% reduction
of TBP binding at the g-gene promoter in comparison with
the wild-type control.
The effects on the CACCC mutant on recruitment of pol II
and TBP extended to the LCR region. As shown in Figure 2C
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Figure 2. Histone acetylation and polII/TBP recruitment measured by ChIP
assays. (A) Measurement of acetylated histone H3 K9, 14 in the LCR and the
g gene regions. The ChIP data are expressed as fold difference by setting the
acetylation level on the mouse b
maj gene promoter as one unit. (B)
Measurement of acetylated histone H4 5, 8, 12, 16 in the LCR and the
g-gene regions. (C) Measurement of TBP recruitment in the LCR and the g-
gene promoter. (D) Measurement of pol II recruitment in the LCR and the
g-gene promoter.
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Figure 1. DNase I hypersensitivity assay. Nuclei from adult spleen of
transgenic mice were treated with DNase I and the partial digested DNA was
restricted with EcoRI. Purified DNA were run on a 0.8% agaroase gel and
blotted onto nylon membrane. The blot was hybridized with a g intron 2
probes. (A) The wild-type control (mLCR-382
Ag). The corresponding HS
sites of the subbands are indicated on left. (B) The CACCC mutant construct
[mLCR-382
Ag(mut)]; (C) A sketch diagram of the constructs and relative
positions of DNase I hypersensitive sites as indicated by arrows. The three
shadow boxes represent exons in the g-globin gene.
3912 Nucleic Acids Research, 2006, Vol. 34, No. 14and D, the TBP recruitment on HS1-4 cores of the LCR
region was reduced, on average, by the CACCC box mutation
to 15% of the wild-type control; the pol II recruitment was
reduced to 28% of the wild type.
Search for the sequences responsible for developmental
specificity in the g CACCC box
In a previous study, we demonstrated that replacement of the
human g CACCC box with either the human e or the galago
g CACCC box resulted in a downregulation of g-gene expres-
sion in adult erythropoiesis, suggesting that the g CACCC
box contributes both to the activation and to the silencing
of the g gene in the adult stage of development (22). It is pre-
sumed that the trans factors that bind to the CACCC box
of the globin genes are putative Kru  ppel-like transcription
factors with three zinc-ﬁnger motifs, such as EKLF. The
zinc-ﬁnger motifs recognize a 9 bp sequence, CCN CNC
CCN. In the human g-gene promoter, this particular sequence
is CTC CAC CCA. We noticed that the common base in
the ‘embryonic’ CACCC box of the human e and galago
g promoters is C at the ninth position, whereas it is A in
the human g CACCC box (Figure 4A). To test whether this
difference could be responsible for the developmental speci-
ﬁcity of the CACCC boxes, a A!C transversion at the
 140 position was introduced into the g CACCC box in
the context of the mLCR( 382)
Ag construct and transgenic
mice were produced. Seven lines were established. Quantita-
tive data of g-gene expression in embryonic and deﬁnitive
erythrocytes are presented in Table 1 (construct C). The
mean level of g-gene expression in yolk sac of the seven
lines was 25.8 ± 7.6%. The corresponding data in the wild-
type control was 21.0 ± 7.4%; the difference was not statisti-
cally signiﬁcant (P > 0.5). In adult blood, the g gene was
expressed at 12.8 ± 5.0% in the  140 mutant mice, a value
similar to that of the wild-type control. We conclude that
the  140 A!C change has no effect on g-gene expression.
However, we noticed that the distribution of g-gene expres-
sion in the  140 A!C mutant transgenic lines was much
diverged. Figure 3A and B show the distribution of g-gene
expression in individual transgenic mice carrying the
 140 A!C mutant along with corresponding data of the
CACCC inactivation mutant ( 142 CC!TG) and the wild-
type control. In embryonic erythropoiesis (Figure 3A), the
distribution of g-gene expression in the  140 A!C mutant
mice was similar to those of the wild type and the CACCC
inactivation mutant transgenic mice, except that it was
slightly wider compared to other two. In adult erythropoiesis,
the levels of g-gene expression could be separated into two
groups (Figure 3B). In ﬁve lines, the mean level of g-gene
expression was similar to wild-type control while two other
lines expressed the g gene at a level similar to that of the
CACCC box inactivated mice and of replacements of the
human e or the galago g CACCC box (22). These results sug-
gest that the 1 bp mutation in the g CACCC box results in an
increase in susceptibility of the gene to position effects from
the surrounding chromatin.
Binding activity of the CACCC boxes
It is likely that the functional speciﬁcities of the various
CACCC boxes reﬂect their distinct binding activity.
Figure 4A shows six different CACCC boxes that have
been tested in transgenic mice. The 9 bases that comprise
the binding motif of a putative zinc-ﬁnger protein are in
capital letters and numbered from 1 to 9 on top. Mutated
base pairs that were introduced into the wild-type human
g CACCC sequence are boxed. Nucleotide differences
between the human g gene and the human e gene or the
galago g gene CACCC boxes are shown in italics. In the
context of the mLCR g constructs, the presence of the
human g CACCC box was associated with an HPFH-like
phenotype, i.e. the g gene is highly expressed during adult
erythropoiesis. The CC!TG mutation of the CACCC box
abolished g-gene expression in adult transgenic mice. Intro-
duction of the ‘down’ mutation (A!C at position 9) resulted
in a high susceptibility of the gene to its surrounding chro-
matin environment, while an ‘up’ T!C transition at position
 4 has no effect on g-gene expression (data not shown).
Replacement of the human g CACCC box with the human
e gene or galago g gene CACCC box resulted in an ‘embry-
onic’ pattern of expression (22). Figure 4B shows the binding
patterns of the six CACCC box oligonucleotides in get shift
assays using MEL nuclear extract. Except for the CC!TG
mutation, which abolished binding activity, all oligonu-
cleotides had a similar binding pattern, suggesting that they
were able to bind identical or very similar factors. However,
the intensity of the major shifted band could be distinguished
between different oligonucleotides, suggesting that the bind-
ing afﬁnities of these sequences were different. The ‘up’
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CACCC at  142 CC!TG); closed circles, transgenic mice carrying
mLCR-382
Ag(mut CACCC at  140 A!C).
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had similar binding afﬁnity as the wild-type g CACCC box.
On other hand, the ‘down’ A!C mutation, which resulted in
an increase of position effect of g-gene expression, and the
human e gene or the galago g gene CACCC box, which
resulted in an ‘embryonic’ expression pattern, had a much
higher binding activity in comparison with the wild-type g
CACCC box. To conﬁrm these observations, quantitative
competition assays were performed.
32P-labeled oligonu-
cleotides of the wild type, down mutation, galago g and
human e CACCC boxes in the same ﬁxed chemical amount
were competed with different amounts of the cold self com-
petitors in gel shift assays (Figure 4C). The retarded bands
were quantiﬁed by PhosphorImager and the resulting data
were plotted against the amount of the competitors
(Figure 4D). The results demonstrated that the wild-type g
CACCC box has a lower binding afﬁnity compared to the
‘down’ mutation, the human e and the galago g CACCC
boxes.
DISCUSSION
Developmentally proper regulation of the globin genes
depends on at least two factors: ﬁrst, the developmental
speciﬁcity of the globin gene promoters; second, the spatial
relationships between the LCR and genes. Alterations in
the developmental proﬁles of globin gene expression have
been observed in many transgenic studies using artiﬁcial con-
structs, including YACs, BACs and cosmids. These changes
provide great opportunities for mechanistic studies of hemo-
globin switching. However, to study a complex phenomenon
like hemoglobin switching, the ideal approach is a reduction-
ist approach dissecting the event into several parameters and
analyzing them one by one. This approach was applied in the
transgenic model we used in these studies. In LCR g gene
mice, the enhancing activity of the LCR is continually avail-
able for the g gene, most likely because of the short distance
between the enhancer and the gene, which spares the require-
ment of loop formation. Therefore, the system allows us to
study the effect of promoter mutations on the transcriptional
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Figure 4. Binding affinity of different CACCC boxes. (A) Sequences of the six CACCC oligonucleotides tested in gel shift assays. The 9 bases that comprise the
binding motif of a putative zinc-finger protein are in capital letters and numbered from 1 to 9 on top and the flanking sequences are in lower case letters. Mutated
base pairs that were introduced into the wild type human g CACCC sequence are boxed. Nucleotide differences between the wild-type human g CACCC and
e gene or galago g gene CACCC boxes are shown in italic. (B) Gel shift assay.
32P-labeled CACCC oligonucleotides (4.5 fmol each) were incubated with nuclear
extracts of MEL cells and separated on a polyacrylamide gel. The probes used on each lane are marked on top. (C) Self-competition.
32P-labeled individual
probes (4.5 fmol) were incubated with various amounts of cold self-competitor (from 0 to 300 fmols as indicated on top of each lane) and gel shift assays were
performed. The major retarded band was quantified by PhosphorImager. The data were used in (D). (D) Plot of concentration of cold self competitor versus
percentage of binding activity of the retarded band compared to the lane with no competitor.
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activity/loop formation remains constant. Using this system
we obtained evidence that the CACCC box is necessary
for the activation of the g gene in deﬁnitive erythropoiesis,
but is not required for the activation of g-gene expression
in primitive cells. Similar results have been reported by
Townes (15) and Sargent and Lloyd (16).
The CACCC box-independent activation of the g-globin
gene in embryonic erythroid cells is an unexpected ﬁnding
in view of the fact that this motif has been documented as
a positive cis element in all tested CACCC box-containing
promoters. Our ﬁndings suggest that the trans factor milieu
in embryonic erythroid cells can support the activation of
the CACCC box-less g gene, and the LCR is able to enhance
transcription from the CACCC box-less g-gene promoter. We
have demonstrated previously that disruption of the TATA
box has no effect on g-gene activation in embryonic erythro-
poiesis (17). Furthermore, the CCAAT box mutation only
moderately impairs g-gene expression in the embryonic
stage (18). We hypothesize that the trans factors bound at
the g-gene promoter interact with each other to form a ‘pro-
moter complex’, which functions as a single entity to interact
with the LCR. In embryonic erythroid cells the LCR is able to
interact with the ‘promoter complex’ even if a component
normally binding with one of the promoter motifs is missing.
In contrast, in adult erythropoiesis the LCR can only interact
with a complete ‘promoter complex’.
Consistent with the abolishment of g-gene expression, the
CACCC mutation resulted in the diminution of HS formation
and TBP and polII recruitments at the g-gene promoter in
adult erythroid cells. In contrast, the g CACCC mutation
resulted in only a slight or no effects on histone H3 and H4
acetylation, suggesting that the activation of the g-globin
gene is not directly related to the level of histone acetylation.
On the other hand, a positive relationship between histone
acetylation and globin gene activation has been established
in the context of the entire globin locus (23–25). This discrep-
ancy could be explained by the hypothesis that histone acety-
lation per se does not directly contribute to gene activation;
instead, it is likely that globin gene activation is regulated
by chromatin loop formation which is modulated by histone
acetylation (26).
The results in this study suggest that each individual base
in the 9 base zinc-ﬁnger binding motif has a distinct effect
on g gene expression. The CC!TG g CACCC mutation
disrupted protein binding and abolished g-gene expression
in adult erythropoiesis. The ‘down’ A!C mutation at
 140g does not seem to alter the type of binding proteins,
but does increase the protein binding afﬁnity in the major
retarded band. The replacement of human g CACCC box
with human e or galago g CACCC box conferred to the
g gene an embryonic expression pattern (22). As seen on
gel shift assay, all three CACCC boxes had higher binding
afﬁnity in comparison to the wild-type g CACCC box.
Based on these observations, we speculate that a change in
binding afﬁnity of the CACCC motif, not necessarily in the
type of the binding proteins, could result in an alteration in
expression pattern. This conclusion is consistent with the
hypothesis that the combination of varying afﬁnity with vary-
ing concentration is important in lineage-speciﬁc expression
of the chicken r-globin gene (27). It should be pointed out
that the 9 base sequence of the zinc-ﬁnger motif in the
A!C mutated g CACCC box is identical to the human e
CACCC box. However, the phenotypes of these two
CACCC boxes were different, suggesting that nucleotides
beyond the 9 base motif may also have a role in determining
the binding property of a zinc-ﬁnger protein in vivo.
This study was designed to assess the transcriptional poten-
tial of the g-gene promoter in different developmental stages,
rather than to delineate the developmental regulation of the
gene. Knowledge of transcriptional potential is essential for
examining the function of the g-gene promoter in the devel-
opmental regulation in the context of the entire locus. For
instance, the ﬁnding that the CACCC box-less g globin
gene has a complete transcriptional potential in embryonic
erythroid cells allow us to determine whether the CACCC
box is required for loop formation between the LCR and
the g gene. The CACCC mutation can be introduced into
the g-gene promoter in a bYAC construct. If the CACCC
box-less g globin gene is expressed in the YAC construct,
the result could suggest that the LCR enhancing activity is
delivered to the gene via loop formation, and the CACCC
box is not required for the event. If the mutated g gene is
not expressed, the most likely explanation will be that the
CACCC box mutation results in a failure of loop formation
between the LCR and the gene.
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